AwardedCzechiaGoodsCZK 18,197,500
Dodávka léčivých přípravků s účinnou látkou Hemihydrát Upadacitinibu
- Published
- Published 27 April 2026
- Deadline
- Closed 27 May 2026
Overview
Moravskoslezská nemocnice Frýdek-Místek procured ongoing supply of pharmaceutical preparations containing Upadacitinib Hemihydrate active ingredient according to the hospital's current needs and individual orders. The contract was awarded to AbbVie s.r.o. on 8 June 2026 for 18,194,742 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 18,197,500
- Procedure
- Open
- Published
- 27 April 2026
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 18,194,742
- Award date
- 8 June 2026
- Contract period
- 30 June 2026 → 30 June 2030
- AbbVie s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
13 July 2026
Contract Notice
27 April 2026
Contracting authority
Moravskoslezská nemocnice Frýdek-Místek, příspěvková organizace
Procuring entityFrýdek-Místek, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.